Alpha Crest Capital Management LLC Seagen Inc. Transaction History

Alpha Crest Capital Management LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 11, 2022	SELL	$108.81 - $179.33 $749,483 - $1.24 Million	-6,888 Closed	0 $0
Q1 2022 May 12, 2022	SELL	$119.61 - $157.85 $2.03 Million - $2.68 Million	-17,008 Reduced 71.18%	6,888 $992,000
Q4 2021 Feb 09, 2022	BUY	$142.57 - $190.86 $3.11 Million - $4.17 Million	21,846 Added 1065.66%	23,896 $3.69 Million
Q3 2021 Nov 10, 2021	SELL	$142.45 - $169.82 $1.79 Million - $2.13 Million	-12,542 Reduced 85.95%	2,050 $348,000
Q2 2021 Aug 12, 2021	SELL	$135.08 - $161.1 $3.36 Million - $4 Million	-24,842 Reduced 63.0%	14,592 $2.3 Million

Q1 2021 May 13, 2021	BUY	$137.51 - $190.8 $4.44 Million - $6.17 Million	32,315 Added 453.93%	39,434 $5.48 Million
Q4 2020 Feb 12, 2021	BUY	$164.63 - $211.93 $1.17 Million - $1.51 Million	7,119 New	7,119 $1.25 Million

1.26M

23K

55.2K

Ticker SGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,664,992
Description
Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...

Get notified when there are updates to the investment portfolio of Alpha Crest Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Alpha Crest Capital Management LLC with notifications on news.